About our medications

Anmed Health Services prescribes compounded GLP-1 medications (compounded tirzepatide and semaglutide) produced in USP (United States Pharmacopeia) certified, state-licensed compounding pharmacies. These medications have NOT been reviewed or approved by the FDA for safety, effectiveness, quality, or purity.

Weight-loss results vary significantly by individual and depend on multiple factors including adherence, pre-existing medical conditions, and individual response to treatment.

GLP-1 medications may have side effects including: nausea, vomiting, diarrhea, constipation, and gastrointestinal discomfort.

Rare but serious risks include acute pancreatitis, gallbladder problems (stones, cholecystitis), serious allergic reactions, and hypoglycemia issues.

DO NOT use if you or your family have a history of: medullary thyroid carcinoma (MTC), multiple endocrine neoplasia syndrome type 2 (MEN 2), or known hypersensitivity to tirzepatide or semaglutide.

Anmed Health Services LLC is the operating entity, with clinical supervision by Annelys Rodriguez, ARNP (Florida License #PENDING). This information does not constitute personalized medical advice and does not replace a clinical evaluation. Consult with your ARNP about benefits and risks before starting.